A biopsy result is only the beginning of surgical planning. Before you choose between removing part or all of the breast, you need to understand the pathology report, stage, lymph-node plan, treatment that may come first, radiotherapy, reconstruction and the practical questions to take to your surgical team.
Key takeaways
- Review tumour type, grade, ER, PR and HER2 results before choosing surgery.
- Ask whether drug treatment should come before the operation.
- Confirm how lymph nodes will be assessed and whether radiotherapy is planned.
- Discuss reconstruction and risk-reducing surgery before finalising the procedure.
What happens after the biopsy confirms breast cancer?
A confirmed biopsy starts treatment planning; a mammogram alone cannot determine the operation. Review the core-needle biopsy or DCIS report for tumour type, grade, ER, PR and HER2 status, because these findings can place drug treatment before surgery.
- Collect the pathology report, slides or tissue blocks if available, mammography and ultrasound reports with images, and any MRI or staging-scan results.
- Review mammography and ultrasound for tumour extent, breast composition and suspicious nodes. Request MRI only when clinical findings, dense breasts, multiple lesions or surgical planning make it useful.
- Establish clinical stage from tumour size and spread on examination and imaging, lymph-node findings, and distant-disease assessment when indicated.
- Discuss the case with a multidisciplinary team that may include a breast surgeon, medical oncologist, radiation oncologist, radiologist, pathologist, plastic surgeon and rehabilitation professional.
| Record | What it clarifies | Possible effect on surgery |
|---|---|---|
| Core-needle biopsy or DCIS report | Invasive cancer or non-invasive DCIS, grade, ER, PR and HER2 | Whether treatment before surgery is useful |
| Mammography and ultrasound | Lesion location, extent and suspicious nodes | Whether conservation is technically reasonable |
| MRI or staging scans | Additional breast or distant disease when indicated | Whether the sequence or operation changes |
A pathology review can change the sequence: HER2-positive or triple-negative disease may benefit from chemotherapy with targeted treatment, while selected hormone-receptor-positive cancers may receive endocrine treatment first. This can shrink disease and support breast conservation, but does not remove surgery when cure remains intended.
That is why breast cancer surgery for after diagnosis in Mumbai should follow confirmed tissue findings and clinical stage, not imaging language alone.
How do lumpectomy, mastectomy and preoperative treatment differ?
Lumpectomy, also called wide local excision, removes the cancer with a rim of normal tissue; mastectomy removes the whole breast. Lumpectomy is suitable when one area can be removed with clear margins and an acceptable breast shape, followed in most cases by whole-breast radiotherapy.
| Option | Main trade-off | When it may apply |
|---|---|---|
| Lumpectomy | Preserves the breast but requires radiotherapy and sometimes re-excision for involved margins | One area, favourable tumour-to-breast ratio, and radiotherapy available |
| Oncoplastic lumpectomy | Removes more tissue while reshaping the breast; may alter both breasts or require balancing surgery | Larger excision where tissue rearrangement or a reduction pattern can improve shape |
| Mastectomy | Removes the breast and does not automatically eliminate radiotherapy; reconstruction becomes a separate decision | Multiple areas, inflammatory or locally advanced cancer, unfavourable tumour-to-breast ratio, unavailable radiotherapy, inherited-risk findings, or informed preference |
A larger tumour does not automatically require mastectomy. Neoadjuvant chemotherapy, anti-HER2 treatment, or selected immunotherapy for triple-negative cancer can shrink disease before surgery and make breast conservation possible. Endocrine treatment before surgery is another option for selected hormone-receptor-positive cancers.
Preoperative treatment can show how the cancer responds, but it does not replace surgery when treatment remains curative. The main breast cancer operation options therefore involve different trade-offs:
- Ask whether clear margins and a satisfactory shape are achievable.
- Confirm whether radiotherapy is practical after lumpectomy.
- Discuss how inflammatory disease, multiple tumour areas, genetic risk, and your preference affect the recommendation.
- Ask whether oncoplastic surgery changes the likely appearance or makes later re-excision more complex.
What will happen to the lymph nodes, and will radiotherapy be needed?
For invasive cancer with no clinically suspicious axillary nodes, sentinel lymph-node biopsy usually replaces immediate full node clearance. A tracer identifies the first-draining nodes, which are removed through a small incision and examined by the pathologist.
| Option | What happens | Main trade-off |
|---|---|---|
| Sentinel-node biopsy | Removes a small number of first-draining nodes | Lower risk of arm numbness, shoulder restriction and lymphoedema |
| Axillary dissection | Removes many more nodes from the armpit | Greater risk of numbness, restricted shoulder movement and lymphoedema |
| No node surgery for selected DCIS | Leaves the axilla undisturbed | Appropriate only when the disease is non-invasive and the operation does not make later mapping unreliable |
A positive sentinel node does not automatically mean axillary dissection. The decision depends on whether you have lumpectomy or mastectomy, planned radiotherapy, the number and size of involved nodes, response after treatment given before surgery and other high-risk features. More extensive nodal disease or residual disease after preoperative treatment may require additional axillary treatment.
DCIS is non-invasive and often needs no node surgery. If mastectomy is planned, sentinel-node biopsy is commonly added because mapping becomes unreliable after the breast is removed.
Lumpectomy is usually followed by whole-breast radiotherapy. Mastectomy may also require radiotherapy when tumour size, involved nodes, margins or tumour biology raise recurrence risk. Confirm radiotherapy availability before choosing the operation; access belongs in the decision from the start.
When should reconstruction or risk-reducing surgery be discussed?
Discuss reconstruction before mastectomy, not after it, because the choice of timing and technique can affect radiotherapy, complications and later operations.
| Option | What it involves | Main timing and trade-off |
|---|---|---|
| Immediate reconstruction | Implant or your own tissue placed during mastectomy | One operation for cancer removal and reconstruction, but radiotherapy can damage reconstructed tissue |
| Delayed reconstruction | Reconstruction after mastectomy and other treatment | Allows radiotherapy and healing first, but requires a later operation and a period without a breast |
| Autologous reconstruction | Tissue transferred from the abdomen, back or another site | Uses your own tissue, but involves longer surgery, donor-site wounds and recovery |
- Ask whether radiotherapy is likely after mastectomy. Tumour size, involved lymph nodes, margins and tumour biology determine that need; mastectomy does not guarantee that radiotherapy can be avoided.
- Discuss smoking, diabetes, obesity and previous operations. These factors can impair wound healing or increase implant and flap complications, making delay or staged reconstruction safer.
- Clarify your recovery priorities. Reconstruction may involve tissue expanders, exchange of an implant, revision surgery or a later balancing procedure on the opposite breast.
- Separate treatment from risk reduction. Removing the unaffected breast does not treat the diagnosed cancer. For average-risk, one-sided disease, it lowers the chance of a new cancer in that breast but does not generally improve survival from the existing cancer.
- Request genetic-risk assessment before bilateral surgery if you have a strong family history or a pathogenic BRCA1, BRCA2 or other germline variant. That result can change whether removal of the unaffected breast is reasonable.
What should you ask at a breast surgery consultation in Mumbai?
Bring complete records to your breast surgery consultation in Mumbai; missing pathology or imaging can force repeat tests and delay a firm plan.
- Biopsy report, plus pathology slides or tissue blocks if available
- Mammography, ultrasound and MRI images with their reports
- Staging results
- Medication list, including anticoagulant name and dose
- Drug allergies, diabetes details, smoking history and family cancer history
Ask the breast cancer surgeon in Mumbai to answer these points clearly:
| Question | Why it matters |
|---|---|
| Clinical stage and ER, PR and HER2 results | These findings shape the operation and drug treatment |
| Is treatment before surgery advised? | Chemotherapy, anti-HER2 treatment or other therapy can change timing |
| What is the margin and re-excision policy? | Cancer at a margin may require another operation |
| What is the lymph-node plan? | Sentinel-node biopsy and dissection have different arm risks |
| What are the anaesthesia, stay, drain, wound-care and pain-control plans? | They define the immediate recovery |
| When will final pathology return? | Results can alter further treatment |
| When can you exercise your arm, drive, lift and work? | These set realistic recovery limits |
| What is the lymphoedema risk, and who coordinates oncology, radiotherapy, reconstruction and rehabilitation? | You need a complete pathway, not surgery in isolation |
Dr Vipul Nandu may be considered when the assessment calls for his surgical expertise, but consultation is not a diagnosis or a promise of one pathway.
Seek a second opinion without cancelling scheduled care. Give the reviewing team the original pathology and imaging, then ask how its recommendation changes with different margins, nodes or treatment response. Ask whether waiting for that review changes a treatment date.
Related service
Breast Cancer Surgery Breast cancer surgery is a primary treatment for breast cancer, aimed at removing cancerous tissue from the breast while preserving healthy tissue... View service → |
Frequently asked questions
What happens after a biopsy confirms breast cancer?
Your team reviews the biopsy or DCIS report, tumour stage and ER, PR and HER2 results before recommending treatment. These findings can place drug treatment before surgery.
How do lumpectomy, mastectomy and preoperative treatment differ?
Lumpectomy removes the cancer with surrounding tissue, while mastectomy removes most or all breast tissue. Preoperative drug treatment happens before surgery when tumour biology or stage makes it useful.
What happens to the lymph nodes, and will radiotherapy be needed?
Your surgeon explains whether lymph-node sampling or dissection is needed. Radiotherapy depends on the operation, pathology, lymph-node findings and other treatment factors.
When should reconstruction or risk-reducing surgery be discussed?
Discuss reconstruction before surgery so it can be planned with the breast procedure. Raise risk-reducing surgery when inherited risk, extensive disease or other clinical findings affect the choices.
What should you ask at a breast surgery consultation in Mumbai?
Ask which operation is recommended, why it fits your biopsy and stage, how lymph nodes will be assessed, whether radiotherapy or drug treatment is expected, and what reconstruction involves.
Keywords
